Fennec Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.

About FENC

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. 

CEO
Jeffrey S Hackman
CEOJeffrey S Hackman
Employees
32
Employees32
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
1996
Founded1996
Employees
32
Employees32

FENC Key Statistics

Market cap
241.61M
Market cap241.61M
Price-Earnings ratio
-16.92
Price-Earnings ratio-16.92
Dividend yield
—
Dividend yield—
Average volume
85.70K
Average volume85.70K
High today
$8.83
High today$8.83
Low today
$8.50
Low today$8.50
Open price
$8.57
Open price$8.57
Volume
36.68K
Volume36.68K
52 Week high
$8.92
52 Week high$8.92
52 Week low
$3.96
52 Week low$3.96

People also own

Based on the portfolios of people who own FENC. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
Ford Motor
Lucid Group
Pfizer
Tilray Brands
NIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.